CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
CorFlow Therapeutics has raised $48.5M in total funding. The most recent round was Series B. The last funding was announced in September 2024.
CorFlow Therapeutics's investors include Wellington Partners, Mérieux Equity Partners, Monte Carlo Capital, Panakes Partners, 415 Capital.
CorFlow Therapeutics is headquartered in Baar, Switzerland.
CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions.
CorFlow Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CorFlow Therapeutics — Funding & Investors." VCBacked, September 10, 2024, https://www.vcbacked.co/company/corflow-therapeutics. Accessed August 16, 2026.
VCBacked. (2024). CorFlow Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/corflow-therapeutics
{{cite web |title=CorFlow Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/corflow-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated